These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 29405469)

  • 1. Immunoassay interference secondary to therapeutic high-dose biotin: A paediatric case report.
    Evans N; Yates J; Tobin J; McGill J; Huynh T
    J Paediatr Child Health; 2018 May; 54(5):572-575. PubMed ID: 29405469
    [No Abstract]   [Full Text] [Related]  

  • 2. [Apparent thyrotoxicosis in a patient with multiple sclerosis: biochemical assay interference due to high dose biotin use].
    van den Berg R; Slim CL; Lutgers HL; de Heide LJM; Wolthuis A
    Ned Tijdschr Geneeskd; 2018 Feb; 162():. PubMed ID: 30730120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Misdiagnosis of Graves' hyperthyroidism due to therapeutic biotin intervention.
    De Roeck Y; Philipse E; Twickler TB; Van Gaal L
    Acta Clin Belg; 2018 Oct; 73(5):372-376. PubMed ID: 29098964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biotin in multiple sclerosis and false biological hyperthyroidism: Mind the interference.
    Willeman T; Casez O; Faure P
    Rev Neurol (Paris); 2017 Mar; 173(3):173-174. PubMed ID: 28302321
    [No Abstract]   [Full Text] [Related]  

  • 5. [Interferences of biotin therapy on immunoassays: It is time for a long-term solution!].
    Denimal D; Nguyen A; Fromont A; Moreau T; Vergès B; Duvillard L
    Presse Med; 2018 Jan; 47(1):95-97. PubMed ID: 29275027
    [No Abstract]   [Full Text] [Related]  

  • 6. Apparent biochemical thyrotoxicosis due to assay interference by high-dose biotin given for multiple sclerosis.
    Cusini C; Sassi L; De Paola G; Piantanida E
    J Endocrinol Invest; 2017 Aug; 40(8):889-890. PubMed ID: 28478548
    [No Abstract]   [Full Text] [Related]  

  • 7. Factitious Graves' Disease Due to Biotin Immunoassay Interference-A Case and Review of the Literature.
    Elston MS; Sehgal S; Du Toit S; Yarndley T; Conaglen JV
    J Clin Endocrinol Metab; 2016 Sep; 101(9):3251-5. PubMed ID: 27362288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoassay design and biotin interference.
    Dasgupta A
    Adv Clin Chem; 2022; 109():165-183. PubMed ID: 35953126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Best practices in mitigating the risk of biotin interference with laboratory testing.
    Bowen R; Benavides R; Colón-Franco JM; Katzman BM; Muthukumar A; Sadrzadeh H; Straseski J; Klause U; Tran N
    Clin Biochem; 2019 Dec; 74():1-11. PubMed ID: 31473202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apparent Hyperthyroidism Caused by Biotin-Like Interference from IgM Anti-Streptavidin Antibodies.
    Lam L; Bagg W; Smith G; Chiu WW; Middleditch MJ; Lim JC; Kyle CV
    Thyroid; 2018 Aug; 28(8):1063-1067. PubMed ID: 29808739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of seborrheic dermatitis with biotin and vitamin B complex.
    Nisenson A; Barness LA
    J Pediatr; 1972 Sep; 81(3):630-1. PubMed ID: 4261960
    [No Abstract]   [Full Text] [Related]  

  • 12. Biotin treatment causing erroneous immunoassay results: A word of caution for clinicians.
    Sulaiman RA
    Drug Discov Ther; 2016; 10(6):338-339. PubMed ID: 28090070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fake news? Biotin interference in thyroid immunoassays.
    Koehler VF; Mann U; Nassour A; Mann WA
    Clin Chim Acta; 2018 Sep; 484():320-322. PubMed ID: 29856977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoassay Disruption by High-Dose Biotin Therapy: Fair Warning for Neonatal Care Physicians.
    Lefèvre CR; Peltier L; Damaj L; Valaize J; Bendavid C; Moreau C
    Pediatr Neurol; 2020 Nov; 112():8-9. PubMed ID: 32823140
    [No Abstract]   [Full Text] [Related]  

  • 15. Biotin interference on TSH and free thyroid hormone measurement.
    Kwok JS; Chan IH; Chan MH
    Pathology; 2012 Apr; 44(3):278-80. PubMed ID: 22437752
    [No Abstract]   [Full Text] [Related]  

  • 16. Biotin interference: Underrecognized patient safety risk in laboratory testing.
    Gifford JL; Sadrzadeh SMH; Naugler C
    Can Fam Physician; 2018 May; 64(5):370. PubMed ID: 29760259
    [No Abstract]   [Full Text] [Related]  

  • 17. [Biotinidase deficiency: the two faces of metabolic screening].
    Pintos-Morell G
    Med Clin (Barc); 2011 Oct; 137(11):497-9. PubMed ID: 21764085
    [No Abstract]   [Full Text] [Related]  

  • 18. Mitochondrial decay, a major cause of aging, can be delayed.
    Ames BN
    J Alzheimers Dis; 2004 Apr; 6(2):117-21. PubMed ID: 15096694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biotinidase Deficiency: A Treatable Neurological Inborn Error of Metabolism.
    Hayek W; Dumin Y; Tal G; Zehavi Y; Sakran W; Spiegel R
    Isr Med Assoc J; 2019 Mar; 21(3):219-221. PubMed ID: 30905112
    [No Abstract]   [Full Text] [Related]  

  • 20. Assessment of biotin interference in thyroid function tests.
    Zhang Y; Wang R; Dong Y; Huang G; Ji B; Wang Q
    Medicine (Baltimore); 2020 Feb; 99(9):e19232. PubMed ID: 32118725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.